Mydecine Innovations Group Closes Sale of Its Wholly-Owned

DENVER, Dec. 12, 2022 (GLOBE NEWSWIRE) -- Mydecine Innovations Group Inc. (“Mydecine” or the “Company”) (NEO:MYCO) (OTC:MYCOF) (FSE:0NFA) a biotechnology...

Related Keywords

Colorado ,United States ,Canada ,United Kingdom ,Netherlands ,Denver ,British ,Canadian ,Pangenomic Nara ,Josh Bartch ,Maryam Marissen ,Joshua Bartch ,Instagram ,Mydecine Innovations Group Inc ,Linkedin ,Twitter ,Canadian Stock Exchange ,Mindleap Health Inc ,Mydecine Innovations Group ,Youtube ,Pangenomic Health Inc ,Innovations Group ,Mindleap Health ,Pangenomic Health ,Each Unit ,Common Share ,Unit Warrant Share ,British Columbia ,Chief Executive ,Aequitas Neo Exchange Myco Ne ,